| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |